Utilizing Tregs to Minimize Immunosuppression Following Transplants

• Explore how Treg therapies can minimize reliance on broad immunosuppressive drugs, reducing side effects
• Review clinical and translational data supporting Treg use to improve transplant outcomes and long-term graft survival

Speakers:

David Mann

General Manager

Singulera Therapeutics